HSC01
clear graphic
clear graphic

Dr. Peterson to lead national PTSD consortium

Posted on Tuesday, August 20, 2013 · Volume: XLVI · Issue: 17


Alan Peterson, Ph.D., (left) a professor of psychiatry, is director of the national STRONG STAR-CAP Consortium. He is pictured with Philip Luber, M.D., vice chair of the Department of Psychiatry, at the news conference Aug.12. Click on images for a larger view
clear graphic
Alan Peterson, Ph.D., (left) a professor of psychiatry, is director of the national STRONG STAR-CAP Consortium. He is pictured with Philip Luber, M.D., vice chair of the Department of Psychiatry, at the news conference Aug.12. Click on images for a larger viewclear graphic

Email Printer Friendly Format
 

Contact: Sheila Hotchkin,
210-567-3026

SAN ANTONIO (Aug. 12, 2013) — In an unprecedented show of support for our nation’s wounded warriors, the U.S. Department of Defense and the U.S. Department of Veterans Affairs have agreed to provide approximately $45 million over five years for post-traumatic stress disorder (PTSD).

The funds will support research to advance PTSD diagnosis, prevention and treatment for service members and veterans.

The University of Texas Health Science Center at San Antonio and the VA National Center for PTSD will lead the consortium, announced recently by the White House and DoD and VA officials.

Funding supports group of PTSD studies
The STRONG STAR Consortium to Alleviate PTSD (STRONG STAR-CAP) will provide an array of cutting-edge clinical treatment trials and biological studies for active military and veterans with PTSD and related conditions, said STRONG STAR-CAP Consortium Director Alan L. Peterson, Ph.D., professor of psychiatry in the School of Medicine at the UT Health Science Center San Antonio. The consortium’s initiatives will include efforts to learn more about the biology/physiology of PTSD development and treatment response to inform diagnosis, prediction of disease outcome, and new or improved treatment methods.
Related link:

“Historically, PTSD has been considered to be a chronic, lifelong disorder that is difficult to treat, particularly in military combat veterans,” Dr. Peterson said. “However, results of studies of PTSD in civilian populations demonstrate that a large percentage of patients have been able to be treated to the point of remission or recovery. Although the term ‘cured’ is rarely used in reference to PTSD, we believe it is possible.”

Many critical questions remain unanswered, said STRONG STAR-CAP Co-Director Terence Keane, Ph.D., of the VA Boston Healthcare System, the National Center for PTSD and Boston University. “Is combat-related PTSD uniquely different and more difficult to treat?” he asked. “Would outcomes improve with early interventions delivered soon after trauma exposure? Can combat-related PTSD be cured? Few national health crises are more deserving of the greatest efforts of the world’s top scientists to answer these questions.”

President William L. Henrich, M.D., MACP, answers questions from the media about the STRONG STAR-CAP program that will support research for post-traumatic stress disorder.
clear graphic
President William L. Henrich, M.D., MACP, answers questions from the media about the STRONG STAR-CAP program that will support research for post-traumatic stress disorder. clear graphic

 

Goal: remission or recovery
STRONG STAR-CAP clinical trials will be conducted to develop programs to treat the largest percentage of service members possible to the point of remission or recovery so that they can remain operationally and functionally fit for military service. The clinical trials will also recruit prior-service veterans to allow them to regain their full potential for social and occupational functioning.

250,000 service members could be affected
Although the majority of service members who are exposed to traumatic events during the course of duty do not go on to develop clinical symptoms that impair functioning, research shows that an estimated 14 percent of members and veterans who have deployed to Iraq and Afghanistan developed symptoms that are significant enough to result in a clinical diagnosis of PTSD. More than 2 million U.S. military personnel have deployed in support of Operation Iraqi Freedom, Operation Enduring Freedom and Operation New Dawn; therefore, an estimated 250,000 service members could be diagnosed with PTSD, resulting in a large financial and personal cost to their families, the Department of Defense, the VA and the nation.

“Our goal is to treat veterans with PTSD to remission. To set our sights any lower would be a disservice to our military warriors, their families and our nation,” Dr. Peterson said. “Those who have fought so hard and sacrificed so much deserve the best our nation can give.”

Advanced treatment for civilians
Additionally, because an estimated 7 percent of the civilian population will develop PTSD at some point, treatment advances made through STRONG STAR-CAP could be applied to help millions more Americans gain a new lease on life.

Largest PTSD research consortium in history
STRONG STAR-CAP has assembled an unprecedented collaboration of highly qualified researchers and clinicians with expertise in PTSD, neuroscience, genetics, traumatic brain injury, suicide, research in military settings, and comorbid conditions such as depression, pain, sleep disturbances and substance abuse. The group includes military clinicians with “boots on the ground” experience in assessing and treating combat-related PTSD. This includes Dr. Peterson himself, a retired U.S. Air Force lieutenant colonel and clinical psychologist who assisted service members suffering PTSD symptoms on the battlefields of Iraq.

STRONG STAR (South Texas Research Organizational Network Guiding Studies on Trauma and Resilience) was initially funded in 2008 by the Department of Defense’s Office of Congressionally Directed Medical Research Programs (CDMRP), part of the U.S. Army’s Medical Research and Materiel Command. For STRONG STAR-CAP, the original STRONG STAR consortium has partnered with the seven divisions of the National Center for PTSD and other VA, military and civilian investigators and institutions across the world to form the largest research consortium in history dedicated to the alleviation of combat-related PTSD.

The Department of Defense plans to award approximately $20.3 million to the UT Health Science Center San Antonio as coordinating center for STRONG STAR-CAP. The Department of Veterans Affairs has committed to provide up to $25 million over five years for the consortium. Funds added by the VA will only be utilized to support research at VA sites; such funding will be managed by the VA Office of Research and Development.

# # #

The University of Texas Health Science Center at San Antonio, one of the country’s leading health sciences universities, ranks in the top 3 percent of all institutions worldwide receiving National Institutes of Health funding. The university’s schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have produced more than 29,000 graduates. The $736 million operating budget supports eight campuses in San Antonio, Laredo, Harlingen and Edinburg. For more information on the many ways “We make lives better®,” visit www.uthscsa.edu.

 
Share |

Top stories this week »



bottom bar

printer friendly format »
view more articles by issue »
search articles by keywords »
Arrow - to top
Arrow - to top